Trials / Terminated
TerminatedNCT01957449
Propranolol in Severely Burned Children
Safety and Efficacy of Propranolol in Severely Burned Children
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- The University of Texas Medical Branch, Galveston · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety and efficacy of administration of propranolol for reducing heart rate and blood pressure in burn injury.
Detailed description
Other purposes of this study are to study the effect on muscle function, the infectious process, sepsis, systemic inflammation and long-term scarring. Quality of life will also be looked at over time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propranolol | Propranolol by mouth given daily throughout hospitalization for up to 12 months |
| DRUG | Placebo | Placebo by mouth given daily throughout hospitalization for up to 12 months. |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2018-12-01
- Completion
- 2019-04-23
- First posted
- 2013-10-08
- Last updated
- 2019-09-24
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01957449. Inclusion in this directory is not an endorsement.